Clinical Trial Update: Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating RICE followed by GARD for relapsed or refractory diffuse large B-cell lymphoma was withdrawn, with no results reported in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• Gallium nitrate (Gallium nitrate)
• IFOSFAMIDE (IFOSFAMIDE)
• Rituximab (rituximab)
• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: Loyola University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: WITHDRAWN